Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Dow
McKinsey
McKesson
Johnson and Johnson
Medtronic

Last Updated: July 2, 2020

DrugPatentWatch Database Preview

Disulfiram - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for disulfiram and what is the scope of patent protection?

Disulfiram is the generic ingredient in two branded drugs marketed by Odyssey Pharms, Teva Womens, Alvogen, Chartwell Molecules, Hikma, Mylan, Par Pharm, Sigmapharm Labs Llc, Watson Labs, and Watson Labs Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for disulfiram. Six suppliers are listed for this compound.

Drug Prices for disulfiram

See drug prices for disulfiram

Recent Clinical Trials for disulfiram

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPhase 2
Amygdala NeurosciencesPhase 2
Reponex Pharmaceuticals A/SPhase 2

See all disulfiram clinical trials

Pharmacology for disulfiram
Medical Subject Heading (MeSH) Categories for disulfiram

US Patents and Regulatory Information for disulfiram

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen DISULFIRAM disulfiram TABLET;ORAL 091681-001 Aug 8, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan DISULFIRAM disulfiram TABLET;ORAL 203916-001 Mar 4, 2015 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Womens ANTABUSE disulfiram TABLET;ORAL 007883-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Par Pharm DISULFIRAM disulfiram TABLET;ORAL 088793-001 Aug 14, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Dow
McKinsey
McKesson
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.